Search

UMass Medical School researcher Guangping Gao has been elected to the American Academy of Microbiology, the honorific leadership group of the American Society of Microbiology.

Guangping Gao, PhD, has been ranked one of the world’s top translational researchers, according to a new tabulation from Nature Biotechnology. The Top 20 Translational Researchers of 2017, published this month by Nature Biotechnology, places Dr. Gao fourth.

An influential scientific journal’s list of top translational biotech researchers for 2019 includes Guangping Gao, PhD. Rankings are based on total patents for the year, among other factors.

Jaime Rivera, PhD, and Guangping Gao, PhD, have developed a new technology using CRISPR/Cas9 technology they believe will help other scientists model human disease more quickly and effectively than allowed by current techniques.

UMass Medical School gene therapy pioneer Guangping Gao has been named a fellow of the National Academy of Inventors.

Terence Flotte, Guangping Gao attend International Conference on Rare Diseases & Orphan Drugs in China

UMass Medical School researchers Guangping Gao, PhD, and Dan Wang, PhD, are working with ASC Therapeutics to bring a gene therapy for maple syrup urine disease (MSUD) to the clinic.

Guangping Gao, PhD, will be honored by the National Tay-Sachs & Allied Diseases Association for his work in identifying the Canavan gene, revitalizing gene therapy, and his many accomplishments leading to potential treatments for Canavan disease.

UMass Medical School researcher Guangping Gao, PhD, spoke with the Telegram & Gazette about research underway at the Li Weibo Institute for Rare Diseases Research.

Fen-Biao Gao, the Governor Paul Cellucci Chair in Neuroscience Research at UMass Medical School, studies the genetic mutations that cause ALS and FTD.